Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
3(25%)
Results Posted
78%(7 trials)

Phase Distribution

Ph early_phase_1
3
25%
Ph phase_1
3
25%
Ph phase_2
1
8%
Ph phase_3
3
25%
Ph not_applicable
2
17%

Phase Distribution

6

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution12 total trials
Early Phase 1First-in-human
3(25.0%)
Phase 1Safety & dosage
3(25.0%)
Phase 2Efficacy & side effects
1(8.3%)
Phase 3Large-scale testing
3(25.0%)
N/ANon-phased studies
2(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

12

all time

Status Distribution
Active(3)
Completed(9)

Detailed Status

Completed9
Recruiting3

Development Timeline

Analytics

Development Status

Total Trials
12
Active
3
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 13 (25.0%)
Phase 13 (25.0%)
Phase 21 (8.3%)
Phase 33 (25.0%)
N/A2 (16.7%)

Trials by Status

recruiting325%
completed975%

Recent Activity

3 active trials
Showing 5 of 12
completedphase_3

A Study to Evaluate the Effect of Genetic Variation on Beta-cell Function During Fasting and Hyperglycemia in Nondiabetics

NCT04466566
recruitingearly_phase_1

Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery

NCT00992901
recruitingearly_phase_1

Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

NCT01803451
recruitingearly_phase_1

The Effects of Bariatric Surgeries on Glucose Metabolism

NCT02823665
completedphase_3

Endogenous GLP-1 Secretion on Islet Function in People With and Without Type 2 Diabetes

NCT04466618
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT04466566Phase 3

A Study to Evaluate the Effect of Genetic Variation on Beta-cell Function During Fasting and Hyperglycemia in Nondiabetics

Completed
NCT00992901Early Phase 1

Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery

Recruiting
NCT01803451Early Phase 1

Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

Recruiting
NCT02823665Early Phase 1

The Effects of Bariatric Surgeries on Glucose Metabolism

Recruiting
NCT04466618Phase 3

Endogenous GLP-1 Secretion on Islet Function in People With and Without Type 2 Diabetes

Completed
NCT04459338Phase 3

A Dose-response Study Examining the Contribution of GLP-1 Receptor Signaling to Glucagon-stimulated Insulin Secretion

Completed
NCT02762708Phase 2

The Effect of Bariatric Surgery on Metabolism, the Metabolome and Microbiome in Patients With Type 2 Diabetes

Completed
NCT02779075Not Applicable

Exendin-9,39 and Satiety After Bariatric Surgery

Completed
NCT00897676Phase 1

Effect of Exendin-(9-39) on Fasting Adaptation and Protein Sensitivity

Completed
NCT02128581Phase 1

A Dose-response of the Effects of Exendin-9,39 on GI Symptoms and Food Intake

Completed
NCT00571324Phase 1

Effect of Exendin-(9-39) on Glycemic Control in Subjects With Congenital Hyperinsulinism

Completed
NCT01162499Not Applicable

Role of Glucagon-Like Peptide-1 in Postprandial Hypoglycemia

Completed

All 12 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
12